Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 - 30, Chicago, IL, USA
22 Novembre 2023 - 5:45PM
Business Wire
- AI Theater Presentation: “Transforming Cancer Diagnosis through
End-to-End AI-Powered SaMD”
- Median’s teams will be at booth #4465, South Hall Level 3, to
present the latest developments on iBiopsy® as well as the imaging
CRO offering.
Regulatory News:
Median Technologies (ALMDT) announced today that the Company
will be speaking and presenting at the world’s largest medical
imaging conference, the Radiological Society of North America
(RSNA) 2023 Annual Meeting and Scientific Assembly, being held in
Chicago, IL, USA, Nov. 26-30, 2023.
The Company will give a presentation. Details of the session
include:
Session: AI Theater Presentation:
Transforming Cancer Diagnosis through End-to-End AI-Powered SaMD
Date: November 26, 2023 - 1:00 pm – 1:15 pm CT Place: South Hall
Level 3, AI showcase theater
Median’s iBiopsy® and iCRO teams will be available at booth
#4465, Level 3 South Hall (AI showcase) for the duration of the
industry exhibition (Nov 26- 29, 10:00 am – 5:00 pm CT).
About Median Technologies: Median Technologies provides
innovative imaging solutions and services to advance healthcare for
everyone. We harness the power of medical images by using the most
advanced Artificial Intelligence technologies, to increase the
accuracy of diagnosis and treatment of many cancers and other
metabolic diseases at their earliest stages and provide insights
into novel therapies for patients. Our iCRO solutions for medical
image analysis and management in oncology trials and iBiopsy®, our
AI/ML tech-based suite of software as medical devices (SaMD), help
biopharmaceutical companies and clinicians to bring new treatments
and diagnose patients earlier and more accurately. This is how we
are helping to create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a
subsidiary in the US and another one in Shanghai, Median has
received the label “Innovative company” by the BPI and is listed on
Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median
is eligible for the French SME equity savings plan scheme
(PEA-PME). For more information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231122023344/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49
24 ggasparetto@actifin.fr
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Median Technologies (EU:ALMDT)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
